The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
MHC class I molecules and kirs in human history, health and survival
Abstract
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly significant differences were seen following genotyping of the mothers, suggesting a broad influence of the genetic background of NK activity, especially given that KIR/HLA complexes are expressed and active in the placenta (Guerini et al, 2014;Parham, 2005).”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Parham, 2005
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C., Gao, X., Astemborski, J. A., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M. W., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,178
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K. W., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,173
Hiby, S. E., Walker, J. J., O’Shaughnessy, K. M., Redman, C. W. G., Carrington, M. N., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,134
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B. C., Tyan, D. B., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,060
Self-citationKIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 984
Self-citationAshkar, A. A., Santo, J. P. D., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 847
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
The role of the maternal immune system in the regulation of human birthweight
Moffett, A., Hiby, S. E., & Sharkey, A. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0071 · Cited by 96
Decidual macrophages and their roles at the maternal-fetal interface.
Houser, B. L. (2012) · Europe PMC (PubMed Central) · Cited by 94
Muccio, L., Bertaina, A., Falco, M., Pende, D., Meazza, R., López‐Botet, M., Moretta, L., Locatelli, F., Moretta, A., & Chiesa, M. D. (2015) · Haematologica · doi:10.3324/haematol.2015.134155 · Cited by 93
Diagnosis and management of extranodal NK/T cell lymphoma nasal type
Tse, E., & Kwong, Y. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1206465 · Cited by 93
Maternal allo-recognition of the fetus
Moffett, A., Chazara, O., & Colucci, F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.001 · Cited by 94
Killer cell immunoglobulin‐like receptors on NK cells: the how, where and why
Gardiner, C. M. (2007) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00739.x · Cited by 92
Karlsen, T. H., Boberg, K. M., Olsson, M., Sun, J., Senitzer, D., Bergquist, A. M., Schrumpf, E., Thorsby, E., & Lie, B. A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.032 · Cited by 92
Maeda, M., Carpenito, C., Russell, R. C., Dasanjh, J., Veinotte, L. L., Ohta, H., Yamamura, T., Tan, R., & Takei, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4426 · Cited by 92
Viertlboeck, B. C., Habermann, F. A., Schmitt, R., Groenen, M. A. M., Pasquier, L. D., & Göbel, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.385 · Cited by 91
Middleton, D., Gonzalez, A. A., & Gilmore, P. M. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.12.007 · Cited by 91
Natural killer cells in the treatment of high-risk acute leukaemia
Locatelli, F., Moretta, F., Brescia, L. P., & Merli, P. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.004 · Cited by 94
Muntasell, A., Cabo, M., Servitja, S., Tusquets, I., Martinez‐García, M., Rovira, A., Rojo, F., Albanell, J., & López‐Botet, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01544 · Cited by 90
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 99
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Malmberg, K., Bryceson, Y. T., Carlsten, M., Andersson, S., Björklund, A. T., Björkström, N. K., Baumann, B. C., Fauriat, C., Alici, E., Dilber, M. S., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0492-7 · Cited by 89
Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation
Masuda, A., Nakamura, A., Maeda, T., Sakamoto, Y., & Takai, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20060631 · Cited by 89
Abi‐Rached, L., Moesta, A. K., Rajalingam, R., Guethlein, L. A., & Parham, P. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001192 · Cited by 88
Self-citationCord Blood as a Source of Natural Killer Cells
Mehta, R. S., Shpall, E. J., & Rezvani, K. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2015.00093 · Cited by 86
Role of KIRs and KIR ligands in hematopoietic transplantation
Velardi, A. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.004 · Cited by 89
Unique Aspects of Rejection and Tolerance in Liver Transplantation
Knechtle, S. J., & Kwun, J. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1192058 · Cited by 85
Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss
Dahl, M., & Hviid, T. V. F. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr043 · Cited by 87
Vidal-Castiñeira, J. R., López‐Vázquez, A., Díaz‐Peña, R., Alonso‐Arias, R., Martı́nez-Borra, J., Pérez, R., Fernández-Suárez, J., Melón, S., Prìeto, J., Rodrigo, L., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01285-09 · Cited by 85
Immune diversity sheds light on missing variation in worldwide genetic diversity panels
Abi‐Rached, L., Gouret, P., Yeh, J.-H., Cristofaro, J. D., Pontarotti, P., Picard, C., & Paganini, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206512 · Cited by 84
Arora, J., Pierini, F., McLaren, P. J., Carrington, M. N., Fellay, J., & Lenz, T. L. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz249 · Cited by 84
Natural killer cells and their receptors in multiple sclerosis
Kaur, G., Trowsdale, J., & Fugger, L. H. (2012) · Brain · doi:10.1093/brain/aws159 · Cited by 89
Innate immunogenetics: a tool for exploring new frontiers of host defence
Bochud, P., Bochud, M., Telenti, A., & Calandra, T. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70185-8 · Cited by 86
Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children
Monsiváis-Urenda, A. E., Noyola, D. E., Hernández‐Salinas, A. E., García-Sepúlveda, C. A., Romo, N., Baranda, L., López‐Botet, M., & González‐Amaro, R. (2010) · European Journal of Immunology · doi:10.1002/eji.200939898 · Cited by 84
The RNA‐binding E3 ubiquitin ligase MEX‐3C links ubiquitination with MHC‐I mRNA degradation
Cano, F., Bye, H., Duncan, L. M., Buchet-Poyau, K., Billaud, M., Wills, M. R., & Lehner, P. J. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.218 · Cited by 84
Sáez‐Borderías, A., Romo, N., Magri, G., Gumá, M., Angulo, A., & López‐Botet, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.829 · Cited by 82
Genetic epidemiology of primary sclerosing cholangitis
Karlsen, T. H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i41.5421 · Cited by 82
Jiang, Y., Chen, O., Cui, C., Zhao, B., Han, X., Zhang, Z., Liu, J., Xu, J., Hu, Q., Liao, C., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-405 · Cited by 81
Leung, W. H., Handgretinger, R., Iyengar, R. V., Turner, V., Holladay, M. S., & Hale, G. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603913 · Cited by 81
Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C
Sim, M. J. W., Rajagopalan, S., Altmann, D. M., Boyton, R. J., Sun, P. D., & Long, E. O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903781116 · Cited by 86
Human Natural Killer Receptors, Co‐Receptors, and Their Ligands
Biassoni, R. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1410s84 · Cited by 84
Forlenza, C. J., Boudreau, J. E., Zheng, J., Luduec, J.-B. L., Chamberlain, E., Heller, G., Cheung, N. V., & Hsu, K. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.9558 · Cited by 83
Boudreau, J. E., Liu, X., Zhao, Z., Zhang, A., Shultz, L. D., Greiner, D. L., Dupont, B., & Hsu, K. C. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.005 · Cited by 80
Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
Oh, S., Lee, J., Kwack, K., & Choi, S. (2019) · Cancers · doi:10.3390/cancers11101534 · Cited by 79
HLA genomics in the third millennium
Trowsdale, J. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.015 · Cited by 79
Hadaya, K., de Rham, C., Bandelier, C., Bandelier, C., Ferrari‐Lacraz, S., Jendly, S., Berney, T., Bühler, L. H., Kaiser, L., Seebach, J. D., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02431.x · Cited by 79
Yoder, J. A., & Litman, G. W. (2010) · Immunogenetics · doi:10.1007/s00251-010-0506-4 · Cited by 77
REVIEW ARTICLE: NK Cell Tolerance and the Maternal–Fetal Interface
Riley, J. K., & Yokoyama, W. M. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00593.x · Cited by 77
Recent advances in understanding immunology of reproductive failure
Makrigiannakis, A., Petsas, G. K., Tóth, B., Relakis, K., & Jeschke, U. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.03.006 · Cited by 75
Vitale, M., Cantoni, C., Chiesa, M. D., Ferlazzo, G., Carlomagno, S., Pende, D., Falco, M., Pessino, A., Muccio, L., Maria, A. D., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01415 · Cited by 76
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus
Pyo, C., Wang, R., Vu, Q., Cereb, N., Yang, S. Y., Duh, F.-M. C., Wolinsky, S. M., Martin, M. P., Carrington, M. N., & Geraghty, D. E. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-89 · Cited by 74
Risk assessment in haematopoietic stem cell transplantation: Histocompatibility
Petersdorf, E. W. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.09.001 · Cited by 74
Strategies of Natural Killer Cell Recognition and Signaling
Stewart, C. A., Vivier, É., & Colonna, M. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_1 · Cited by 74
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
Sola, C., André, P., Lemmers, C., Fuséri, N., Bonnafous, C., Bléry, M., Wagtmann, N. R., Romagné, F., Vivier, É., & Ugolini, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901653106 · Cited by 73
Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation
Hanvesakul, R., Spencer, N., Cook, M. A., Gunson, B. K., Hathaway, M., Brown, R., Nightingale, P., Cockwell, P., Hübscher, S. G., Adams, D., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02341.x · Cited by 73
KIR gene content diversity in four Iranian populations
Ashouri, E., Farjadian, S., Reed, E. F., Ghaderi, A. A., & Rajalingam, R. (2009) · Immunogenetics · doi:10.1007/s00251-009-0378-7 · Cited by 73
Middleton, D., Meenagh, A., Moscoso, J., & Arnaiz‐Villena, A. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00973.x · Cited by 71
Jiao, Y., Ma, C., Wang, L., Cui, B., Zhang, J., Li, Y., Chen, Z., Li, J., & Zhao, Y. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9183-6 · Cited by 71
Identification of bidirectional promoters in the human KIR genes
Davies, G. E., Locke, S., Wright, P. W., Li, H., Hanson, R. J., Miller, J. S., & Anderson, S. K. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364381 · Cited by 71
A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates
Averdam, A., Petersen, B., Rosner, C., Neff, J., Roos, C., Eberle, M., Aujard, F., Münch, C., Schempp, W., Carrington, M. N., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000688 · Cited by 72
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
Matsuda, M., Ono, R., Iyoda, T., Endo, T. A., Iwasaki, M., Tomizawa-Murasawa, M., Saito, Y., Kaneko, A., Shimizu, K., Yamada, D., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800195 · Cited by 71
Littera, R., Piredda, G., Argiolas, D., Lai, S., Congeddu, E., Ragatzu, P., Melis, M., Carta, E., Michittu, M. B., Valentini, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180831 · Cited by 71
Denney, L., Aitken, C., Li, C. K.-F., Wilson-Davies, E., Kok, W. L., Clelland, C., Rooney, K., Young, D., Dong, T., McMichael, A. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010675 · Cited by 70
Killer Immunoglobulin-like Receptors and Tumor Immunity
Benson, D. M., & Caligiuri, M. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0219 · Cited by 70
Primate‐specific regulation of natural killer cells
Parham, P., Abi‐Rached, L., Matevosyan, L., Moesta, A. K., Norman, P. J., Aguilar, A. M. O., & Guethlein, L. A. (2010) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2010.00432.x · Cited by 69
Self-citationKiller cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations
Hollenbach, J. A., Nocedal, I., Ladner, M. B., Single, R. M., & Trachtenberg, E. (2012) · Immunogenetics · doi:10.1007/s00251-012-0629-x · Cited by 71
Primary sclerosing cholangitis
Karlsen, T. H., Schrumpf, E., & Boberg, K. M. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.005 · Cited by 70
Konjević, G. M., Martinović, K. M., Jurišić, V., Babović, N. L., & Spužić, I. (2009) · Biomarkers · doi:10.1080/13547500902814658 · Cited by 69
Overview of the Killer Cell Immunoglobulin-Like Receptor System
Rajalingam, R. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-842-9_23 · Cited by 74
Gelao, L., Criscitiello, C., Espósito, A., Goldhirsch, A., & Curigliano, G. (2014) · Toxins · doi:10.3390/toxins6030914 · Cited by 68
Eissens, D., van der Meer, A., van Cranenbroek, B., Preijers, F. W. M. B., & Joosten, I. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03242.x · Cited by 68
The role of natural killer cells in immunity against multiple myeloma
Godfrey, J. K., & Benson, D. M. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.676175 · Cited by 70
NK Cell-Based Immunotherapy for Hematological Malignancies
Sivori, S., Meazza, R., Quintarelli, C., Carlomagno, S., Chiesa, M. D., Falco, M., Moretta, L., Locatelli, F., & Pende, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101702 · Cited by 68
Innate Immunity, Decidual Cells, and Preeclampsia
Yeh, C.-C., Chao, K.-C., & Huang, S.-T. J. (2012) · Reproductive Sciences · doi:10.1177/1933719112450330 · Cited by 68
Chan, W. K., Rujkijyanont, P., Neale, G. A. M., Yang, J., Bari, R., Gupta, N., Holladay, M. S., Rooney, B., & Leung, W. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300111 · Cited by 67
NK Cells: Uncertain Allies against Malaria
Wolf, A., Sherratt, S., & Riley, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00212 · Cited by 67
Straub, C., Neulen, M.-L., Sperling, B., Windau, K., Zechmann, M., Jansen, C. A., Viertlboeck, B. C., & Göbel, T. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.03.013 · Cited by 68
Variable NK Cell Receptors Exemplified by Human KIR3DL1/S1
Parham, P., Norman, P. J., Abi‐Rached, L., & Guethlein, L. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0902332 · Cited by 66
Self-citationWhat is natural in natural killer cells?
Vivier, É. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.07.004 · Cited by 66
Preynat‐Seauve, O., de Rham, C., Tirefort, D., Ferrari‐Lacraz, S., Krause, K., & Villard, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00746.x · Cited by 66
Giustiniani, J., Bensussan, A., & Marie‐Cardine, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.63 · Cited by 66
Besson, C., Roetynck, S., Williams, F., Orsi, L., Amiel, C., Lependeven, C., Antoni, G., Hermine, O., Brice, P., Fermé, C., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000406 · Cited by 64
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
Sarkar, S., van Gelder, M., Noort, W. A., Xu, Y., Rouschop, K. M. A., Groen, R. W. J., Schouten, H. C., Tilanus, M. G. J., Germeraad, W. T. V., Martens, A. C., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1694-4 · Cited by 64
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
Rodríguez, J., López‐Botet, M., Munteis, E., Río, J., Roquer, J., Montalbán, X., & Comabella, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.006 · Cited by 64
Ortiz‐Fernández, L., Carmona, F. D., Montes-Cano, M.-A., Garcı́a-Lozano, J.-R., Conde‐Jaldón, M., Ortego‐Centeno, N., Castillo, M. J., Espinosa, G., Gil, J. G., Sánchez‐Bursón, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161305 · Cited by 64
Mancusi, A., Ruggeri, L., & Velardi, A. (2016) · Blood · doi:10.1182/blood-2016-07-730564 · Cited by 64
Expression estimation and eQTL mapping for HLA genes with a personalized pipeline
Aguiar, V. R. C., Cesar, J. E. D. S., Delaneau, O., Dermitzakis, E. T., & Meyer, D. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008091 · Cited by 64
Alomar, S. Y., Marshall, E., Middleton, D., & Christmas, S. E. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03415.x · Cited by 63
Endosomal Signaling and a Novel Pathway Defined by the Natural Killer Receptor KIR2DL4 (CD158d)
Rajagopalan, S. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01112.x · Cited by 67
Gurevich, M., Gritzman, T., Orbach, R., Tuller, T., Feldman, A., & Achiron, A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.010 · Cited by 63
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M., & Geller, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01825 · Cited by 64
Hallner, A., Bernson, E., Hussein, B. A., Sander, F. E., Brune, M. L., Aurelius, J., Martner, A., Hellstrand, K., & Thorén, F. B. (2019) · Blood · doi:10.1182/blood-2018-09-874990 · Cited by 63
Giustiniani, J., Marie‐Cardine, A., & Bensussan, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1293 · Cited by 63
Crosley, E. J., Elliot, M. G., Christians, J. K., & Crespi, B. J. (2013) · Placenta · doi:10.1016/j.placenta.2012.12.001 · Cited by 62
Yabe, T., Matsuo, K., Hirayasu, K., Kashiwase, K., Kawamura-Ishii, S., Tanaka, H., Ogawa, A., Takanashi, M., Satake, M., Nakajima, K., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.09.012 · Cited by 62
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function
Chiesa, M. D., Romeo, E., Falco, M., Balsamo, M., Augugliaro, R., Moretta, L., Bottino, C., Moretta, A., & Vitale, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838434 · Cited by 62
Saito, H., Osaki, T., & Ikeguchi, M. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0059-8 · Cited by 62
TRPML Cation Channels in Inflammation and Immunity
Spix, B., Chao, Y., Abrahamian, C., Chen, C., & Grimm, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00225 · Cited by 63
Adaptive NK cell response to human cytomegalovirus: Facts and open issues
López‐Botet, M., Maria, A. D., Muntasell, A., Chiesa, M. D., & Vilches, C. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101706 · Cited by 65
Engineering immune-evasive allogeneic cellular immunotherapies
Martin, K. E., Hammer, Q., Perica, K., Sadelain, M., & Malmberg, K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01022-8 · Cited by 64
KIR and KIR ligand polymorphism: a new area for clinical applications?
Falco, M., Moretta, L., Moretta, A., & Bottino, C. (2013) · Tissue Antigens · doi:10.1111/tan.12262 · Cited by 61
Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis
Lorentzen, Å. R., Karlsen, T. H., Olsson, M., Smestad, C., Mero, I., Woldseth, B., Sun, J., Senitzer, D., Celius, E. G., Thorsby, E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21695 · Cited by 61
Ameres, S., Mautner, J., Schlott, F., Neuenhahn, M., Busch, D. H., Plachter, B., & Moosmann, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003383 · Cited by 61
Current Progress of CAR-NK Therapy in Cancer Treatment
Pang, Z., Wang, Z., Li, F., Feng, C., & Mu, X. N. (2022) · Cancers · doi:10.3390/cancers14174318 · Cited by 60
Portevin, D., Via, L. E., Eum, S., & Young, D. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01834.x · Cited by 60
KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations
Flores, A. C., Marcos, C. Y., Paladino, N., Capucchio, M., Theiler, G., Arruvito, L., Pardo, R., Habegger, A., Williams, F., Middleton, D., et al. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00824.x · Cited by 60
Identification of the ancestral killer immunoglobulin-like receptor gene in primates
Sambrook, J. G., Bashirova, A. A., Andersen, H., Piatak, M., Vernikos, G. S., Coggill, P. C., Lifson, J. D., Carrington, M. N., & Beck, S. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-209 · Cited by 60
KIR/HLA Ligand Incompatibility in Kidney Transplantation
Kunert, K., Seiler, M., Mashreghi, M., Klippert, K., Schönemann, C., Neumann, K., Pratschke, J., Reinke, P., Volk, H., & Kotsch, K. (2007) · Transplantation · doi:10.1097/01.tp.0000290681.41859.41 · Cited by 59
Metadata
- Authors
- Parham, P.
- Affiliations
- Stanford University (US)
- Corresponding author
- Parham, Peter
- ORCID
- Parham, Peter
- Venue
- Nature Reviews Immunology
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 201-214
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2008919922
- Cited by
- 1,203
- References
- 125
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 35 · 2023: 23 · 2022: 44 · 2021: 38 · 2020: 43 · 2019: 54 · 2018: 46 · 2017: 50 · 2016: 57 · 2015: 55 · 2014: 57 · 2013: 95 · 2012: 77
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- MHC class I, killer cell immunoglobulin-like receptors, natural killer cells, T cells, infection resistance, autoimmune disease susceptibility, pregnancy complications, hematopoietic stem cell transplantation, human survival, immune system evolution, reproduction
- MeSH terms
- Animals, Autoimmune Diseases, Communicable Diseases, Humans, Lymphocytes, Neoplasms, Receptors, Immunologic, Histocompatibility Antigens Class I, Models, Immunological, Evolution, Molecular, Receptors, KIR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review